发明名称 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS
摘要 There are disclosed compounds of Formula (I) or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
申请公布号 WO02083624(A1) 申请公布日期 2002.10.24
申请号 WO2002US12681 申请日期 2002.04.15
申请人 SCHERING CORPORATION;PHARMACOPEIA, INC. 发明人 TAVERAS, ARTHUR, G.;AKI, CYNTHIA, J.;BOND, RICHARD, W.;CHAO, JIANPING;DWYER, MICHAEL;FERREIRA, JOHAN, A.;CHAO, JIANHUA;YU, YOUNONG;BALDWIN, JOHN, J.;KAISER, BERND;LI, GE;MERRITT, J., ROBERT;NELSON, KINGSLEY, H.;ROKOSZ, LAURA, L.
分类号 C07D249/18;A61K31/166;A61K31/167;A61K31/341;A61K31/343;A61K31/36;A61K31/381;A61K31/397;A61K31/40;A61K31/401;A61K31/41;A61K31/415;A61K31/416;A61K31/4192;A61K31/42;A61K31/4245;A61K31/433;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/443;A61K31/445;A61K31/495;A61K31/496;A61K31/506;A61K31/5375;A61K31/54;A61K31/55;A61K45/00;A61P1/04;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/06;A61P17/10;A61P19/02;A61P25/28;A61P27/02;A61P31/04;A61P35/00;A61P37/06;A61P37/08;A61P39/02;A61P43/00;C07C225/20;C07C237/30;C07C237/44;C07C255/59;C07D205/04;C07D207/08;C07D207/16;C07D211/32;C07D211/60;C07D213/40;C07D213/74;C07D213/76;C07D213/78;C07D213/82;C07D231/44;C07D239/42;C07D239/47;C07D241/04;C07D257/06;C07D261/08;C07D271/06;C07D277/06;C07D277/28;C07D285/06;C07D295/16;C07D307/14;C07D307/52;C07D307/56;C07D307/78;C07D317/58;C07D333/20;C07D333/28;C07D333/36;C07D333/38;C07D401/04;C07D403/04;C07D405/12;C07D409/04;C07D409/12;C07D413/04;C07D413/12;C07D413/14 主分类号 C07D249/18
代理机构 代理人
主权项
地址